ANKRD29 and neoplasm: To validate the expression level of ANKRD29 in clinical NSCLC samples, the immunohistochemistry (IHC) assay was applied in NSCLC tissue microarrays (TMA) containing 80 NSCLC tumor tissues and paired adjacent normal tissues.